HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Shimada Selected Research

kamikihi-to (KKT)

1/2019Kihito, a Traditional Japanese Kampo Medicine, Improves Cognitive Function in Alzheimer's Disease Patients.
1/2014New Treatment for Alzheimer's Disease, Kamikihito, Reverses Amyloid-β-Induced Progression of Tau Phosphorylation and Axonal Atrophy.
1/2011Traditional Japanese formula kigikenchuto accelerates healing of pressure-loading skin ulcer in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Shimada Research Topics

Disease

73Neoplasms (Cancer)
03/2019 - 01/2002
34Esophageal Squamous Cell Carcinoma
07/2017 - 01/2002
23Esophageal Neoplasms (Esophageal Cancer)
04/2016 - 07/2002
16Lymphatic Metastasis
07/2018 - 01/2002
15Neoplasm Metastasis (Metastasis)
01/2017 - 07/2002
13Carcinogenesis
01/2015 - 01/2002
12Carcinoma (Carcinomatosis)
02/2017 - 06/2002
11Stomach Neoplasms (Stomach Cancer)
02/2017 - 06/2002
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 09/2003
6Non-alcoholic Fatty Liver Disease
03/2014 - 10/2006
5Breast Neoplasms (Breast Cancer)
03/2019 - 08/2010
5Inflammation (Inflammations)
03/2014 - 09/2006
5Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2012 - 01/2007
5Rheumatoid Arthritis
12/2008 - 08/2003
5Hemolysis
05/2005 - 06/2002
4Circulating Neoplastic Cells
01/2017 - 08/2013
4Obesity
01/2015 - 01/2012
4Body Weight (Weight, Body)
03/2010 - 09/2005
3Drug-Related Side Effects and Adverse Reactions
01/2019 - 12/2017
3Hypertension (High Blood Pressure)
04/2016 - 10/2008
3Fibrosis (Cirrhosis)
03/2014 - 10/2006
3Hyperlipidemias (Hyperlipidemia)
03/2014 - 04/2008
3Barrett Esophagus (Barrett's Esophagus)
12/2013 - 05/2004
3Human Influenza (Influenza)
01/2013 - 12/2002
3Insulin Resistance
01/2012 - 01/2007
3Stroke (Strokes)
01/2011 - 01/2003
3Atherosclerosis
02/2005 - 06/2002
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 12/2017
2Alzheimer Disease (Alzheimer's Disease)
01/2019 - 01/2014
2Chemical and Drug Induced Liver Injury
06/2018 - 06/2002
2Aggressive Fibromatosis (Desmoid)
01/2017 - 09/2016
2Adenocarcinoma
12/2013 - 03/2005
2Bile Reflux
12/2013 - 10/2007
2Colorectal Neoplasms (Colorectal Cancer)
12/2013 - 06/2002
2Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2013 - 01/2003
2Alcoholic Fatty Liver
09/2012 - 03/2008

Drug/Important Bio-Agent (IBA)

18Messenger RNA (mRNA)IBA
01/2015 - 01/2002
14keishibukuryoganIBA
01/2015 - 06/2002
9Proteins (Proteins, Gene)FDA Link
03/2011 - 09/2003
8Complementary DNA (cDNA)IBA
01/2013 - 12/2002
7MicroRNAs (MicroRNA)IBA
08/2016 - 01/2011
6Pharmaceutical PreparationsIBA
03/2019 - 03/2005
6Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
07/2017 - 09/2006
6Biomarkers (Surrogate Marker)IBA
03/2017 - 10/2007
6Cisplatin (Platino)FDA LinkGeneric
05/2016 - 12/2003
6Biological ProductsIBA
01/2015 - 09/2002
6ParaffinIBA
07/2011 - 01/2004
6DNA (Deoxyribonucleic Acid)IBA
07/2007 - 01/2002
5CholesterolIBA
03/2010 - 06/2002
5choto-sanIBA
12/2007 - 01/2003
4Eosine Yellowish-(YS) (Eosin)IBA
07/2018 - 01/2002
4Epithelial Cell Adhesion MoleculeIBA
01/2017 - 02/2016
4LipidsIBA
03/2014 - 01/2007
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2012 - 08/2002
4LigandsIBA
04/2012 - 08/2003
42,2'-azobis(2-amidinopropane) (ABAP)IBA
05/2005 - 06/2002
3Ephedrae herbaIBA
01/2022 - 06/2006
3kamikihi-to (KKT)IBA
01/2019 - 01/2011
3AntigensIBA
01/2018 - 01/2006
3EnzymesIBA
07/2015 - 12/2004
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2015 - 08/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 06/2002
3Plant ExtractsIBA
01/2015 - 12/2002
3Sodium Glutamate (Accent)IBA
03/2014 - 01/2012
3InterferonsIBA
12/2011 - 01/2002
3CytokinesIBA
01/2011 - 04/2007
3Fibronectins (Fibronectin)IBA
01/2011 - 09/2005
3fascinIBA
06/2010 - 01/2004
3Small Interfering RNA (siRNA)IBA
05/2009 - 02/2006
3Oncogene Proteins (Oncogene Protein)IBA
05/2008 - 07/2005
3Glucose (Dextrose)FDA LinkGeneric
04/2008 - 01/2007
3OsteopontinIBA
12/2007 - 01/2005
3RNA (Ribonucleic Acid)IBA
07/2007 - 12/2006
3Blood Glucose (Blood Sugar)IBA
03/2007 - 09/2005
3squamous cell carcinoma-related antigenIBA
11/2005 - 07/2002
3Hematoxylin (Haematoxylon)IBA
11/2005 - 01/2002
3AntioxidantsIBA
04/2005 - 12/2004
3ProstaglandinsIBA
05/2004 - 01/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2004 - 01/2002
3nitrosobenzylmethylamineIBA
03/2003 - 09/2002
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
07/2018 - 01/2011
2ErbB Receptors (EGF Receptor)IBA
01/2018 - 04/2006
2AntibodiesIBA
01/2018 - 01/2017
2Phosphates (Orthophosphate)IBA
04/2016 - 08/2013
2Matrix Metalloproteinases (MMPs)IBA
01/2015 - 01/2002
2Interleukin-6 (Interleukin 6)IBA
01/2015 - 08/2002
2Vascular Endothelial Growth Factor CIBA
01/2015 - 12/2013
2Analgesics (Analgesic Drugs)IBA
01/2015 - 12/2002
2Indicators and Reagents (Reagents)IBA
01/2014 - 11/2005
2SuspensionsIBA
08/2013 - 06/2002
2Phosphotransferases (Kinase)IBA
01/2013 - 04/2006

Therapy/Procedure

25Kampo Medicine (Kampo)
01/2022 - 01/2002
13Therapeutics
01/2017 - 01/2004
9Drug Therapy (Chemotherapy)
01/2015 - 12/2003
6Esophagectomy
08/2016 - 01/2007
5Oral Administration
01/2015 - 01/2003
3Lab-On-A-Chip Devices
01/2018 - 08/2013
3Adjuvant Chemotherapy
02/2014 - 12/2003
2Heavy Ion Radiotherapy
01/2017 - 09/2016
2Gastrectomy
12/2013 - 11/2013